CoChat

The DOI matches its Crossref record; 200 of the 201 references it cites were found in a registry or an index.

Inositols: From Established Knowledge to Novel Approaches

Open access

Abstract

Myo-inositol (myo-Ins) and D-chiro-inositol (D-chiro-Ins) are natural compounds involved in many biological pathways. Since the discovery of their involvement in endocrine signal transduction, myo-Ins and D-chiro-Ins supplementation has contributed to clinical approaches in ameliorating many gynecological and endocrinological diseases. Currently both myo-Ins and D-chiro-Ins are well-tolerated, effective alternative candidates to the classical insulin sensitizers, and are useful treatments in preventing and treating metabolic and reproductive disorders such as polycystic ovary syndrome (PCOS), gestational diabetes mellitus (GDM), and male fertility disturbances, like sperm abnormalities. Moreover, besides metabolic activity, myo-Ins and D-chiro-Ins deeply influence steroidogenesis, regulating the pools of androgens and estrogens, likely in opposite ways. Given the complexity of inositol-related mechanisms of action, many of their beneficial effects are still under scrutiny. Therefore, continuing research aims to discover new emerging roles and mechanisms that can allow clinicians to tailor inositol therapy and to use it in other medical areas, hitherto unexplored. The present paper outlines the established evidence on inositols and updates on recent research, namely concerning D-chiro-Ins involvement into steroidogenesis. In particular, D-chiro-Ins mediates insulin-induced testosterone biosynthesis from ovarian thecal cells and directly affects synthesis of estrogens by modulating the expression of the aromatase enzyme. Ovaries, as well as other organs and tissues, are characterized by a specific ratio of myo-Ins to D-chiro-Ins, which ensures their healthy state and proper functionality. Altered inositol ratios may account for pathological conditions, causing an imbalance in sex hormones. Such situations usually occur in association with medical conditions, such as PCOS, or as a consequence of some pharmacological treatments. Based on the physiological role of inositols and the pathological implications of altered myo-Ins to D-chiro-Ins ratios, inositol therapy may be designed with two different aims: (1) restoring the inositol physiological ratio; (2) altering the ratio in a controlled way to achieve specific effects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms221910575

Cites

200 of 200 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Structure of nine isomers of inositol. Myo-inositol and D-chiro-inositol are the most common isomers of inositol.
Figure 1 Structure of nine isomers of inositol. Myo-inositol and D-chiro-inositol are the most common isomers of inositol.CC BY · PubMed Central
Figure 2 Synthesis, sources and role of myo-inositol and D-chiro-inositol in insulin signaling pathway. Abbreviations: G6P, glucose-6-phosphate; MIPS1, myo-inositol-phosphate synthase; IMPase, inositol monophosphatase; IP3, inositol-trisphosphate; IP2, inositol-biphosphate; MI, myo-inositol; DCI, D-chiro-inositol; GLUT4, glucose transporter type 4; FFA, free fatty acids; IRS2, insulin receptor type 2; PI3K, phosphoinositide 3-kinase; GSK3β, glycogen synthase kinase 3β.
Figure 2 Synthesis, sources and role of myo-inositol and D-chiro-inositol in insulin signaling pathway. Abbreviations: G6P, glucose-6-phosphate; MIPS1, myo-inositol-phosphate synthase; IMPase, inositol monophosphatase; IP3, inositol-trisphosphate; IP2, inositol-biphosphate; MI, myo-inositol; DCI, D-chiro-inositol; GLUT4, glucose transporter type 4; FFA, free fatty acids; IRS2, insulin receptor type 2; PI3K, phosphoinositide 3-kinase; GSK3β, glycogen synthase kinase 3β.CC BY · PubMed Central
Figure 3 Insulin-mimetic action of D-chiro-Ins (DCI). Both insulin and D-chiro-Ins stimulate testosterone production by theca cell. Antibodies, Ⓐ, against this glycan block testosterone production.
Figure 3 Insulin-mimetic action of D-chiro-Ins (DCI). Both insulin and D-chiro-Ins stimulate testosterone production by theca cell. Antibodies, Ⓐ, against this glycan block testosterone production.CC BY · PubMed Central
Figure 4 Myo-inositol and D-chiro-inositol affect aromatase activity in an opposite manner. Abbreviations: FSH, follicular stimulating hormone; FSHR, FSH receptor; MI, myo-inositol; DCI, D-chiro-inositol; PKA, protein kinase A; A, androgen; E, estrogen; LOH, late onset hypogonadism.
Figure 4 Myo-inositol and D-chiro-inositol affect aromatase activity in an opposite manner. Abbreviations: FSH, follicular stimulating hormone; FSHR, FSH receptor; MI, myo-inositol; DCI, D-chiro-inositol; PKA, protein kinase A; A, androgen; E, estrogen; LOH, late onset hypogonadism.CC BY · PubMed Central
Figure 5 Insulin stimulates epimerase enzyme to convert myo-inositol (MI) to D-chiro-inositol (DCI). The classic insulin target tissues of PCOS women with insulin resistance (IR) show less epimerase activity and consequently result in a systemic deficiency of DCI. Ovaries of PCOS women with IR maintain the normal insulin sensitivity (“ovarian paradox”); the hyperinsulinemia overstimulates epimerase to convert MI to DCI, resulting in a pathological increase in DCI.
Figure 5 Insulin stimulates epimerase enzyme to convert myo-inositol (MI) to D-chiro-inositol (DCI). The classic insulin target tissues of PCOS women with insulin resistance (IR) show less epimerase activity and consequently result in a systemic deficiency of DCI. Ovaries of PCOS women with IR maintain the normal insulin sensitivity (“ovarian paradox”); the hyperinsulinemia overstimulates epimerase to convert MI to DCI, resulting in a pathological increase in DCI.CC BY · PubMed Central
Figure 6 The curly tail model is genetically not responsive to preventive folic acid, exposing pregnant mice to a high neural tube defect (NTD) rate. Preconception supplementation with myo-inositol (MI) may prevent NTD occurrence, lowering the NTD rate.
Figure 6 The curly tail model is genetically not responsive to preventive folic acid, exposing pregnant mice to a high neural tube defect (NTD) rate. Preconception supplementation with myo-inositol (MI) may prevent NTD occurrence, lowering the NTD rate.CC BY · PubMed Central
Figure 7 α-lactalbumin (α-LA) increases myo-inositol (MI) passage across intestinal cellular monolayer, causing a temporary opening of the tight junctions between the cells.
Figure 7 α-lactalbumin (α-LA) increases myo-inositol (MI) passage across intestinal cellular monolayer, causing a temporary opening of the tight junctions between the cells.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 200 references

Research works printed but not linked: 2

  1. Maquenne, 1887, Préparation, proprietés et constitution se l’inosite, CR Hebd. Séance Acad. Sci. Paris, 104, 225
  2. 2021, D-Chiro-Inositol, vitamin D and epigallocatechin gallate avoid surgery in women with uterine fibroids: 2 case reports, Eur. Med. J., 9, 95

Cited by

See all 162

Metadata

Authors
Dinicola, S., Unfer, V., Facchinetti, F., Soulage, C. O., Greene, N. D., Bizzarri, M., Laganà, A. S., Chan, S.-Y., Bevilacqua, A., Pkhaladze, L., Benvenga, S., Stringaro, A., Barbaro, D., Appetecchia, M., Aragona, C., Bezerra Espinola, M. S., Cantelmi, T., Cavalli, P., Chiu, T. T., Copp, A. J., D’Anna, R., Dewailly, D., Di Lorenzo, C., Diamanti-Kandarakis, E., Hernández Marín, I., Hod, M., Kamenov, Z., Kandaraki, E., Monastra, G., Montanino Oliva, M., Nestler, J. E., Nordio, M., Ozay, A. C., Papalou, O., Porcaro, G., Prapas, N., Roseff, S., Vazquez-Levin, M., Vucenik, I., & Wdowiak, A.
Affiliations
  • Systems Biology Group Lab, 00161 Rome, Italy
  • University of Modena and Reggio Emilia (IT)
  • Lyon 1 Université (FR)
  • University College London (GB)
  • Sapienza University of Rome (IT)
  • University of Insubria (IT)
  • National University of Singapore (SG)
  • Zhordania and Khomasuridze Institute of Reproductology, Tbilisi 0112, Georgia
  • University of Messina (IT)
  • Istituto Superiore di Sanità (IT)
  • Ospedale di Livorno (IT)
  • Instituto Nazionale Tumori Regina Elena (IT)
  • Institute for Interpersonal Cognitive Therapy, 00100 Rome, Italy
  • IRCCS Humanitas Research Hospital (IT)
  • IVF Centre, Hong Kong 999077, China
  • Université de Lille (FR)
  • Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome Polo Pontino, 04100 Latina, Italy
  • Department of Endocrinology and Diabetes, HYGEIA Hospital, Marousi, 15123 Athens, Greece
  • Human Reproduction Department, Hospital Juárez de México, Universidad Nacional Autónoma de México (UNAM), Mexico City 07760, Mexico
  • Tel Aviv University (IL)
  • Medical University of Sofia (BG)
  • Hygeia Hospital (GR)
  • Department of Obstetrics and Gynecology, Santo Spirito Hospital, 00193 Rome, Italy
  • Virginia Commonwealth University (US)
  • A.S.L. RMF, 00053 Civitavecchia, Italy
  • Department of Obstetrics and Gynecology, Near East University Hospital, Nicosia 99138, Cyprus
  • Azienda Unità Sanitaria Locale Umbria n. 2 (IT)
  • Iakentro (GR)
  • Reproductive Endocrinology and Infertility, South Florida Institute for Reproductive Medicine (IVFMD), Boca Raton, FL 33458, USA
  • Instituto de Biología y Medicina Experimental (IBYME, CONICET-FIBYME), Consejo Nacional de Investigaciones Científicas y Técnicas de Argentina (CONICET), Buenos Aires 2490, Argentina
  • Department of Medical & Research Technology and Pathology, School of Medicine, University of Maryland, Baltimore, MD 21201, USA
  • Medical University of Lublin (PL)
Corresponding author
Facchinetti, Fabio
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2021-09-30
Volume
22
Issue
19
Pages
10575
ISSN
1422-0067 (ISSN-L)
OpenAlex
W3203286644
Cited by
154
References
201
Citations by year
2026: 24 · 2025: 30 · 2024: 29 · 2023: 43 · 2022: 27 · 2021: 1
FWCI
4.11
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, cc-by)
  • National University of Singapore (submittedVersion, cc-by)
  • HAL (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
  • LillOA (Université de Lille (University Of Lille)) (submittedVersion)
Funders
  • Action Medical Research
  • Sparks (17ICH03)
  • Medical Research Council (MR/T003847/1)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Keywords
myo-inositol, D-chiro-inositol, steroidogenesis, aromatase, testosterone production, polycystic ovary syndrome, gestational diabetes mellitus, male fertility, sperm abnormalities, insulin sensitizers, inositol supplementation
MeSH terms
Female, Humans, Inositol, Polycystic Ovary Syndrome, Pregnancy, Testosterone, Theca Cells, Molecular Structure, Signal Transduction, Diabetes, Gestational

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inositols: From Established Knowledge to Novel Approaches. https://app.cochat.ai/papers/10.3390/ijms221910575
The paper
Dinicola, S., Unfer, V., Facchinetti, F., Soulage, C. O., Greene, N. D., Bizzarri, M., Laganà, A. S., Chan, S.-Y., Bevilacqua, A., Pkhaladze, L., Benvenga, S., Stringaro, A., Barbaro, D., Appetecchia, M., Aragona, C., Bezerra Espinola, M. S., Cantelmi, T., Cavalli, P., Chiu, T. T., . . . Wdowiak, A. (2021). Inositols: From Established Knowledge to Novel Approaches. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms221910575

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.